Susan Harley
Assistant Professor
faculty
Pathology, College of Medicine
Research Areas
Biography and Research Information
OverviewAI-generated summary
Susan Harley's research focuses on molecular mechanisms in disease, particularly in the context of cancer and genetic disorders. She has investigated acquired resistance to isocitrate dehydrogenase 1 (IDH1) inhibitor therapy, examining full-exon sequencing and structural modeling of the IDH1 gene. Harley also studies the correlation of PDL1 expression with genomic alterations in non-small cell lung cancer. Her work includes exploring clinical insights from rare genetic conditions like Wolman disease, which causes infantile hepatosplenomegaly. Additionally, she has contributed to research on the SARS-CoV-2 Lambda variant in a pediatric case from Arkansas. Harley's scholarship metrics include an h-index of 3, with 9 total publications and 36 total citations. She has collaborated with researchers such as David W. Ussery, Jordan T. Bird, Joshua L. Kennedy, and Bobby L. Boyanton at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 3
- Publications: 9
- Citations: 37
Selected Publications
-
The Era of Molecular Hematopathology (2024)
-
Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced (2023)
-
Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly (2022)
-
Classic hairy cell leukemia with an aggressive presentation (2021)
-
A Synoptic Reporting System to Monitor Bone Marrow Aspirate and Biopsy Quality (2021)
Collaboration Network
Top Collaborators
- Assessing acquired resistance to IDH1 inhibitor therapy by full-exon <i>IDH1</i> sequencing and structural modeling
- Correlation of PDL1 Expression with Genomic Alterations in Non-Small Cell Lung Cancer: a 7-month retrospective analysis
- Assessing acquired resistance to IDH1 inhibitor therapy by full-exon <i>IDH1</i> sequencing and structural modeling
- Correlation of PDL1 Expression with Genomic Alterations in Non-Small Cell Lung Cancer: a 7-month retrospective analysis
- Assessing acquired resistance to IDH1 inhibitor therapy by full-exon <i>IDH1</i> sequencing and structural modeling
- Correlation of PDL1 Expression with Genomic Alterations in Non-Small Cell Lung Cancer: a 7-month retrospective analysis
- Assessing acquired resistance to IDH1 inhibitor therapy by full-exon <i>IDH1</i> sequencing and structural modeling
- Assessing acquired resistance to IDH1 inhibitor therapy by full-exon <i>IDH1</i> sequencing and structural modeling
- Assessing acquired resistance to IDH1 inhibitor therapy by full-exon <i>IDH1</i> sequencing and structural modeling
- Assessing acquired resistance to IDH1 inhibitor therapy by full-exon <i>IDH1</i> sequencing and structural modeling
- A Synoptic Reporting System to Monitor Bone Marrow Aspirate and Biopsy Quality
- A Synoptic Reporting System to Monitor Bone Marrow Aspirate and Biopsy Quality
- A Synoptic Reporting System to Monitor Bone Marrow Aspirate and Biopsy Quality
- A Synoptic Reporting System to Monitor Bone Marrow Aspirate and Biopsy Quality
- A Synoptic Reporting System to Monitor Bone Marrow Aspirate and Biopsy Quality
- Classic hairy cell leukemia with an aggressive presentation
- Classic hairy cell leukemia with an aggressive presentation
- Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly
Similar Researchers
Based on overlapping research topics